- Home
- CRBP vs LESL Comparison
CRBP vs LESL Comparison
Compare CRBP & LESL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- LESL
- Stock Information
- Founded
- CRBP 2009
- LESL 1963
- Country
- CRBP United States
- LESL United States
- Employees
- CRBP N/A
- LESL N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- LESL Diversified Commercial Services
- Sector
- CRBP Health Care
- LESL Miscellaneous
- Exchange
- CRBP Nasdaq
- LESL Nasdaq
- Market Cap
- CRBP 96.5M
- LESL 81.4M
- IPO Year
- CRBP N/A
- LESL 2020
- Fundamental
- Price
- CRBP $8.22
- LESL $0.44
- Analyst Decision
- CRBP Strong Buy
- LESL Hold
- Analyst Count
- CRBP 10
- LESL 10
- Target Price
- CRBP $53.56
- LESL $1.91
- AVG Volume (30 Days)
- CRBP 215.8K
- LESL 5.6M
- Earning Date
- CRBP 08-05-2025
- LESL 08-06-2025
- Dividend Yield
- CRBP N/A
- LESL N/A
- EPS Growth
- CRBP N/A
- LESL N/A
- EPS
- CRBP N/A
- LESL N/A
- Revenue
- CRBP N/A
- LESL $1,319,859,000.00
- Revenue This Year
- CRBP N/A
- LESL $1.64
- Revenue Next Year
- CRBP $270.04
- LESL $2.74
- P/E Ratio
- CRBP N/A
- LESL N/A
- Revenue Growth
- CRBP N/A
- LESL N/A
- 52 Week Low
- CRBP $4.64
- LESL $0.40
- 52 Week High
- CRBP $61.90
- LESL $4.22
- Technical
- Relative Strength Index (RSI)
- CRBP 54.23
- LESL 36.49
- Support Level
- CRBP $7.26
- LESL $0.41
- Resistance Level
- CRBP $7.90
- LESL $0.52
- Average True Range (ATR)
- CRBP 0.53
- LESL 0.05
- MACD
- CRBP -0.01
- LESL 0.01
- Stochastic Oscillator
- CRBP 78.59
- LESL 28.75
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About LESL Leslie's Inc.
Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products across chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company offers its products and services for Residential Pool, Residential Spa, Professional Pool, and Commercial Pool consumers. Geographically, it operates only in the United States.